This study examines the correspondence between retrospective and prosp
ective assessments of treatment outcomes among female patients treated
for gynecologic symptoms (n = 800) and male patients having surgery f
or benign prostatic hyperplasia (n = 434). The overall health and symp
tom status of patients in both samples was assessed at enrollment and
again 3 months after treatment; at the 3-month follow-up, patients als
o were asked to compare retrospectively their current health and how t
hey were feeling with their condition before treatment. Findings indic
ate that prospective and retrospective measures of change do not yield
the same results. Retrospective assessments consistently produce high
er estimates of the benefits of treatment, although that pattern was c
learer for overall health status than for measures of symptoms. Patien
ts' posttreatment health and symptom status contributes as much to ret
rospective assessments of change as does prospectively measured change
, although the retrospective assessments of female patients whose gyne
cologic symptoms were medically managed were more strongly related to
prospective change than those of hysterectomy patients or prostate sur
gery patients. Overall, we conclude that these alternative measurement
strategies yield divergent assessments of change, depending on the ty
pe of treatment a patient receives and, to some extent, what is being
measured.